What’s New

News & Announcements

OBI-992 Shortlisted as the Most Promising Clinical Candidate in the 11th Annual World ADC Awards

OBI-992 has been approved by US FDA for Orphan Drug Designation for the treatment of gastric cancer

OBI’s Proprietary ADC Platform GlycOBI® Seeks Collaborative Partnerships for Development

OBI Shares Opportunities and Challenges of ADC Development at BioAsia2024

Events

2024 2nd ADC Linker & Conjugation Summit

  • 2024.Aug.20 ~ 2024.Aug.22
  • W Boston 100 Stuart Street, Boston, MA 02116, United States
  • Event Time2024.Aug.20 ~ 2024.Aug.22
  • Event LocationW Boston 100 Stuart Street, Boston, MA 02116, United States
  • Video URLhttps://adc-linker-conjugation.com/
  • Published Date2024.Aug.13

2024 BIO Asia-Taiwan

  • 2024.Jul.24 ~ 2024.Jul.28
  • TaiNEX, (No. 1, Jingmao 2nd Rd., Nangang Dist., Taipei City), Taiwan (R.O.C.)

2024 Annual Shareholders’ Meeting

  • 2024.Jun.17 at 09:00 AM
  • Masterlink Securities Education and Training Center
  • Event Time2024.Jun.17
  • Event LocationMasterlink Securities Education and Training Center
  • Published Date2024.May.14